title: Phase II trial of 6-thioguanine in advanced renal cell carcinoma. An Illinois Cancer Center study.
authors.affiliation: Evanston Hospital, Division of Medical Oncology, IL 60201, USA.
authors.forename: D H
authors.initials: DH
authors.lastname: Shevrin
authors.forename: L J
authors.initials: LJ
authors.lastname: Kilton
authors.forename: T E
authors.initials: TE
authors.lastname: Lad
authors.forename: M
authors.initials: M
authors.lastname: Mullane
authors.forename: B
authors.initials: B
authors.lastname: Esparaz
authors.forename: R
authors.initials: R
authors.lastname: Knop
authors.forename: J
authors.initials: J
authors.lastname: Egner
authors.forename: P
authors.initials: P
authors.lastname: Johnson
authors.forename: R
authors.initials: R
authors.lastname: Blough
authors.forename: S
authors.initials: S
authors.lastname: French
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D013866:Thioguanine / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D013866:Thioguanine